Literature DB >> 20554943

Tamoxifen and the factor V Leiden mutation.

Jack Cuzick.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20554943     DOI: 10.1093/jnci/djq225

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  2 in total

1.  Additional Utility of Pharmacogenomics (PGx) Panel Testing in a CYP2D6 Normal Metabolizer with a History of Breast Cancer.

Authors:  Michael J Schuh
Journal:  Innov Pharm       Date:  2019-07-18

2.  Flavones inhibit breast cancer proliferation through the Akt/FOXO3a signaling pathway.

Authors:  Chia-Hung Lin; Ching-Yao Chang; Kuan-Rong Lee; Hui-Ju Lin; Ter-Hsin Chen; Lei Wan
Journal:  BMC Cancer       Date:  2015-12-16       Impact factor: 4.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.